Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Pasithea Therapeutics Corp (KTTA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Pasithea Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
6.920 +0.060    +0.87%
30/04 - Closed. Currency in USD ( Disclaimer )
After Hours
6.710
-0.210
-3.035%
19:43:06 - Real-time Data
  • Volume: 335
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 6.900 - 6.920
Type:  Equity
Market:  United States
Pasithea Therapeutics 6.920 +0.060 +0.87%

Pasithea Therapeutics Corp Company Profile

 
Get an in-depth profile of Pasithea Therapeutics Corp, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

15

Equity Type

ORD

Pasithea Therapeutics Corp. is a biotechnology company. The Company is primarily focused on the discovery, research and development of treatments for Central Nervous System (CNS) disorders and RASopathies. The Company operates through two segments: Therapeutics and Clinics. Its Therapeutics segment performs activities related to the discovery, research, and development of treatments for CNS disorders and other diseases. Its Clinics segment provides business support services to anti-depression clinics in the United Kingdom and in the United States. Its therapeutic pipeline consists of four programs. Its lead product candidate, PAS-004, is a macrocyclic mitogen-activated protein kinase (MEK) inhibitor for potential use in the treatment of a range of RASopathies, including neurofibromatosis type 1 (NF1) and Noonan syndrome, as well as lamin A/C (LMNA) cardiomyopathy and a number of oncology indications. Its other three programs are in the discovery stage.

Contact Information

Address 1111 Lincoln Road Suite 500
Miami Beach, 33139
United States
Phone 702 514 4174
Fax -

Top Executives

Name Age Since Title
Tiago Reis Marques 44 2020 CEO & Director
Emer Leahy 55 2021 Independent Director
Simon Dumesnil 45 2021 Independent Director
Daniel R. Weinberger - 2022 Member of Scientific Advisory Board
Alfred J. Novak 75 2022 Independent Director
Lawrence Steinman 76 2020 Co-Founder, MD & Executive Chairman
Merit E. Cudkowicz 60 2022 Member of Scientific Advisory Board
Luca Rastelli 56 - Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

KTTA Comments

Write your thoughts about Pasithea Therapeutics Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mehedi Hasan
Mehedi Hasan Nov 29, 2021 11:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Must buy
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email